(Q43686221)

25 November 2017

Vigabatrin effect on inner retinal function (English)

1 reference

25 November 2017

Coupland SG

1

1 reference

25 November 2017

Zackon DH

series ordinal

2

1 reference

25 November 2017

Leonard BC

series ordinal

3

1 reference

25 November 2017

Ross TM

series ordinal

4

1 reference

25 November 2017

1 August 2001

1 reference

25 November 2017

1 reference

25 November 2017

108

1 reference

25 November 2017

1493-6; discussion 1497-8

1 reference

25 November 2017

8

1 reference

Severe persistent visual field constriction associated with vigabatrin

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900638-8

7 January 2021

Severe persistent visual field constriction associated with vigabatrin. Chronic refractory epilepsy may have role in causing these unusual lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900638-8

7 January 2021

Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900638-8

7 January 2021

Symptomatic and asymptomatic visual loss in patients taking vigabatrin.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900638-8

7 January 2021

Visual dysfunction in patients receiving vigabatrin: clinical and electrophysiologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900638-8

7 January 2021

Standard for clinical electroretinography (1994 update)

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900638-8

7 January 2021

Standard for clinical electro-oculography. International Society for Clinical Electrophysiology of Vision.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900638-8

7 January 2021

Diversity of GABA receptors in the vertebrate outer retina

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900638-8

7 January 2021

Activity-dependent transport of GABA analogues into specific cell types demonstrated at high resolution using a novel immunocytochemical strategy.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900638-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900638-8

1 reference

7 January 2021

Different contributions of GABAA and GABAC receptors to rod and cone bipolar cells in a rat retinal slice preparation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900638-8

7 January 2021

Development of tolerance to the effects of vigabatrin (gamma-vinyl-GABA) on GABA release from rat cerebral cortex, spinal cord and retina

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900638-8

7 January 2021

Immunocytochemical evidence that vigabatrin in rats causes GABA accumulation in glial cells of the retina

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900638-8

7 January 2021

The Müller cell: a functional element of the retina

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900638-8

7 January 2021

Intracellular responses of the Müller (glial) cells of mudpuppy retina: their relation to b-wave of the electroretinogram

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900638-8

7 January 2021

Visual function loss from vigabatrin: effect of stopping the drug

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900638-8

7 January 2021

Separating the retinal electrophysiologic effects of vigabatrin: treatment versus field loss

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2801%2900638-8

7 January 2021

10.1016/S0161-6420(01)00638-8

Identifiers

DOI

1 reference

25 November 2017

1 reference